EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Correlation of TP53 Mutations With p53 Expression and Ki‐67 Index in Pulmonary Large Cell Neuroendocrine Carcinomas

Martin Stampe iD, Jonas Smidt, Linea Melchior iD, Morten Grauslund, Birgitte Federspiel, Eric Santoni-Rugiu, Thomas Hartvig Lindkær Jensen

APMIS · 2026-04 · 134 (4)

DOI: 10.1111/apm.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, online erschienen am 30.03.2026. Verfasst von Martin Stampe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Ki-67 Antigen, Tumor Suppressor Protein p53, Carcinoma, Neuroendocrine, Mutation. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores the locations and distribution of mutations in the exons of the TP53 gene in pulmonary large cell neuroendocrine carcinomas (LCNEC) and the corresponding expression of p53 as well as the Ki‐67 proliferation index. Real‐world data from routine diagnostics were collected retrospectively from 149 consecutive cases of pulmonary LCNEC. They included next‐generation sequencing (NGS) of the TP53 gene along with evaluation of p53 and Ki‐67 expression with immunohistochemistry (IHC). Abnormal p53 expression was defined as strong positive nuclear reaction in more than 20% of the tumor cells or complete absence of immunostaining in tumor cells. Both p53 expression and Ki‐67 proliferation index correlated with TP53 mutations. In addition, a statistically significant increase in Ki‐67 expression was found for cases with abnormal staining of p53 compared to samples with normal staining. We found that IHC staining for p53 can identify TP53 mutations in pulmonary LCNEC with an overall concordance of 76.6%. Moreover, both pathological patterns of p53 immunostaining and NGS‐detected TP53 mutations were associated with higher Ki‐67 proliferation indices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-67 AntigenTumor Suppressor Protein p53Carcinoma, NeuroendocrineMutationLung NeoplasmsCarcinoma, Large CellHumansImmunohistochemistryFemaleRetrospective StudiesMaleMiddle AgedAgedHigh-Throughput Nucleotide SequencingAdult

Stichwörter der Autor:innen

Ki‐67TP53 mutations and p53 expressionimmunohistochemistrypulmonary large cell neuroendocrine carcinomasthoracic pathology

Substanzen

Ki-67 AntigenTumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • BRIC - Biotech Research & Innovation Centre, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Martin Stampe, Linea Melchior

Zitieren

APA

Stampe, M., Smidt, J., Melchior, L., Grauslund, M., Federspiel, B., Santoni-Rugiu, E., & Jensen, T. H. L. (2026). Correlation of TP53 Mutations With p53 Expression and Ki‐67 Index in Pulmonary Large Cell Neuroendocrine Carcinomas. APMIS, 134(4). https://doi.org/10.1111/apm.70189

Vancouver

Stampe M, Smidt J, Melchior L, Grauslund M, Federspiel B, Santoni-Rugiu E, et al. Correlation of TP53 Mutations With p53 Expression and Ki‐67 Index in Pulmonary Large Cell Neuroendocrine Carcinomas. APMIS. 2026;134(4). doi:10.1111/apm.70189

BibTeX
@article{Stampe2026,
  author = {Stampe, Martin and Smidt, Jonas and Melchior, Linea and Grauslund, Morten and Federspiel, Birgitte and Santoni-Rugiu, Eric and Jensen, Thomas Hartvig Lindkær},
  title = {Correlation of TP53 Mutations With p53 Expression and Ki‐67 Index in Pulmonary Large Cell Neuroendocrine Carcinomas},
  journal = {APMIS},
  year = {2026},
  volume = {134},
  number = {4},
  doi = {10.1111/apm.70189}
}
Kostenlos starten →